Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Betof Warner

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|August 9, 2023
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle InterventionsAllison Betof Warner
Current Oncology Reports|July 3, 2019
Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the MicrobiomeAllison Betof Warner, Jennifer L McQuade
Oncology (Williston Park, N.Y.)|May 31, 2018
Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?Allison Betof Warner, Michael A Postow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over InterferonAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced MelanomaAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-IIAllison Betof Warner, Jason J Luke
The Lancet. Oncology|February 26, 2018
The brim of uncertainty in adjuvant treatment of melanomaAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2022
Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the FutureAllison Betof Warner, Pippa G Corrie, Omid Hamid
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 13, 2022
Adoptive Cell Transfer and Vaccines in Melanoma: The Horizon Comes Into ViewAllison Betof-Warner, Ryan J Sullivan, Amod Sarnaik
Transplantation and Cellular Therapy|March 15, 2025
The Clinical TIL Experience in Melanoma: Past, Present, FutureJames W Smithy, Adam J Schoenfeld, Allison Betof Warner
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|August 9, 2023
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle InterventionsAllison Betof Warner
Current Oncology Reports|July 3, 2019
Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the MicrobiomeAllison Betof Warner, Jennifer L McQuade
Oncology (Williston Park, N.Y.)|May 31, 2018
Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?Allison Betof Warner, Michael A Postow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over InterferonAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced MelanomaAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-IIAllison Betof Warner, Jason J Luke
The Lancet. Oncology|February 26, 2018
The brim of uncertainty in adjuvant treatment of melanomaAllison Betof Warner, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2022
Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the FutureAllison Betof Warner, Pippa G Corrie, Omid Hamid
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 13, 2022
Adoptive Cell Transfer and Vaccines in Melanoma: The Horizon Comes Into ViewAllison Betof-Warner, Ryan J Sullivan, Amod Sarnaik
Transplantation and Cellular Therapy|March 15, 2025
The Clinical TIL Experience in Melanoma: Past, Present, FutureJames W Smithy, Adam J Schoenfeld, Allison Betof Warner
Pageof 6